Gold-Facilitated in Situ Hybridization
- 1 May 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 160 (5) , 1589-1595
- https://doi.org/10.1016/s0002-9440(10)61106-6
Abstract
No abstract availableKeywords
Funding Information
- Cleveland Clinic Foundation (1R11 CA83618-01)
- National Cancer Institute (1R11 CA83618-01)
- Small Business Technology Transfer (1R11 CA83618-01)
This publication has 40 references indexed in Scilit:
- Breast Cancer Tests: Her 2/neu Versus FISH TestLaboratory Medicine, 2001
- Strong Correlation between Results of Fluorescent In Situ Hybridization and Immunohistochemistry for the Assessment of the ERBB2 (HER-2/neu) Gene Status in Breast CarcinomaLaboratory Investigation, 2000
- HER-2/neu assessment in breast cancer by immunohistochemistry and fluorescence in situ hybridization: Comparison of results and correlation with survivalMolecular Diagnosis, 2000
- Comparison of PathVysion and INFORM fluorescence in situ hybridization kits for assessment of HER-2/neu status in breast carcinomaMolecular Diagnosis, 2000
- HER-2/neu Testing in Breast Carcinoma: A Combined Immunohistochemical and Fluorescence In Situ Hybridization ApproachLaboratory Investigation, 2000
- Sensitivity of HER-2/neu Antibodies in Archival Tissue Samples of Invasive Breast CarcinomasAmerican Journal of Clinical Pathology, 2000
- Determination of Her-2/Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ HybridizationLaboratory Investigation, 2000
- The Quality of Her-2/Neu Predictive Immunohistochemistry: Something FISHy?Laboratory Investigation, 2000
- HER-2/neu Assessment in Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization: Comparison of Results and Correlation With SurvivalMolecular Diagnosis, 2000
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989